,
Simona Stager,1,
,¶
Sara Prickett,2,||
Asher Maroof,1,
Soombul Zubairi,1,
Deborah F. Smith,2,
and
Paul M. Kaye1*
Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT United Kingdom,1 Wellcome Trust Laboratories for Molecular Parasitology, Department of Biological Sciences, Imperial College London, London, SW7 2AZ United Kingdom2
Received 26 July 2005/ Accepted 13 September 2005
CD8+ T cells have a protective role in experimental visceral leishmaniasis. However, the observation that inflammatory cytokines induce bystander activation of CD8+ T cells questions the need for antigen-dependent effector function. Here, we demonstrate that successful adoptive immunotherapy with CD8+ T cells is strictly dependent upon the presence of cognate antigen.
These authors contributed equally to this work.
Present address: Lymphocyte Biology Section, Laboratory of Immunology, NIAID/National Institutes of Health, Bethesda, MD 20892.
¶ Present address: Division of Biomedical Sciences, Johns Hopkins in Singapore, 31 Biopolis Way, 02-01 The Nanos, Singapore 138669, Republic of Singapore.
|| Present address: Division of Infection and Immunity, Walter and Eliza Hall Institute, 1G Royal Parade, Parkville, Victoria 3050, Australia.
Present address: Immunology and Infection Unit, Dept. of Biology, University of York, P.O. Box 373, York, YO10 5YW United Kingdom.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|